Click here to subscribe to Biomedical Materials and immediately access all its archives
Click here to review the contents of the January 2006 issue of Biomedical Materials and download it online
Issue: January 2006, page: 10
Human clinical trial scheduled for local bone regeneration
Aastrom Biosciences Inc will start a human clinical trial for the evaluation of the company’s tissue repair cells (TRCs) to form new bone tissue in the spine, following approval from the US Food and Drug Administration (FDA). It will be carried out under an Investigational New Drug (IND) application and will start out initially at a single clinical centre—the William Beaumont Hospital in Royal Oak, Michigan, USA.
